Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 13Neoplasms 8Breast Neoplasms 7Neoplasm Metastasis 5Prostatic Neoplasms 4Pancreatic Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Urogenital Neoplasms 1Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Solid Tumor 1Sarcoma, Ewing 1Prostatic Diseases 1Prostate Carcinoma Metastatic to the Bone 1Ovarian Diseases 1Osteosarcoma 1Neuroblastoma 1Neoplasm, Residual 1Melanoma 1Lung Neoplasms 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1HER2-negative Metastatic Breast Cancer 1Gonadal Disorders 1Genital Neoplasms, Male 1Genital Neoplasms, Female 1Genital Diseases, Male 1Genital Diseases, Female 1

Interventions

pembrolizumab 3Cyclophosphamide 3fludarabine 2Rosuvastatin Calcium 2Radiotherapy 2Paclitaxel 2Ipilimumab 2Interleukin-2 2Carboplatin 2spartalizumab 1peposertib 1osimertinib 1niraparib 1neotil 1necitumumab 1mirdametinib 1apatinib 1amivantamab 1Valganciclovir 1Tomography, X-Ray Computed 1Rifampin 1Radiation 1Positron-Emission Tomography 1PankoMab-GEX 1Panitumumab 1Nivolumab 1Midazolam 1Metformin 1Magnetic Resonance Imaging 1MEK inhibitor I 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumor, Adult × niraparib × Clear all
NCT03209401 2024-02-05

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

Georgetown University

Phase 1 Terminated
23 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡